A company with a start-up mentality and a history that spans more than 150 years, Mallinckrodt is an industry leader with an exceedingly capable, engaged workforce. Come grow your career with us.

Mallinckrodt Pharmaceuticals plc is an American-Irish domiciled manufacturer of specialty pharmaceuticals (namely, adrenocorticotropic hormone), generic drugs and imaging agents. [2] In 2017, it generated 90% of its sales from the U.S. healthcare system.

As a global specialty pharmaceutical company, Mallinckrodt has been making the complex simple for more than 150 years. Visit the website to learn more.

Mallinckrodt has a diverse portfolio of branded products available across a broad range of indications and a broad line of speciality generics. Visit our website to learn about our product offerings.

2023年8月30日 · Drugmaker Mallinckrodt's opioid creditors will support an expedited second bankruptcy, despite a "gruesome" $1 billion reduction in settlement money for victims of the U.S. opioid crisis,...

Mallinckrodt Pharmaceuticals is pleased to announce the launch of its 2025 Internship Program. The U.S. program will commence the week of May 19th and will continue through August 1st.

Updated Mallinckrodt Statement on Extended-Release Methylphenidate Tablets. Our personalized customer portal allows you to view shipment information and track status, find orders that are currently open and have not shipped, gain access to customer service personnel dedicated to your account, and many other features.

Working in their favor was the fact that St. Louis was fast becoming a major commercial center because of the railroad and the development of the Mississippi River. As the only chemical manufacturing company west of Philadelphia, Mallinckrodt was able to capture much of the newly emerging western markets.

Mallinckrodt is uniquely suited to help strengthen the US pharmaceutical supply chain with its five US-based manufacturing sites and the capability to manufacture both API and finished dose medicines. We are also the only large-scale domestic vertically integrated manufacturer, from starting material to finished dose pharmaceuticals.

affecting Mallinckrodt’s businesses and any other statements regarding events or developments that the company believes or antic ipates will or may occur in the future, may be "forward- looking" statements within the meaning of the Private ... net; share- based compensation; fresh-start related expenses; and other items identified by the ...